Volume | 522,613 |
|
|||||
News | - | ||||||
Day High | 49.08 | Low High |
|||||
Day Low | 47.87 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
QuidelOrtho Corporation | QDEL | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
48.35 | 47.87 | 49.08 | 47.94 | 48.26 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
8,400 | 522,613 | $ 48.41 | $ 25,297,167 | - | 41.75 - 98.67 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
18:08:48 | 2 | $ 45.745 | USD |
QuidelOrtho (QDEL) Options Flow Summary
QuidelOrtho Corporation Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
3.2B | 66.85M | - | 3B | -10.1M | -0.15 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
QuidelOrtho News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical QDEL Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 47.56 | 49.08 | 46.62 | 47.37 | 739,947 | 0.38 | 0.80% |
1 Month | 45.60 | 49.185 | 42.305 | 46.63 | 903,061 | 2.34 | 5.13% |
3 Months | 72.57 | 75.09 | 41.75 | 51.75 | 1,051,919 | -24.63 | -33.94% |
6 Months | 71.18 | 75.855 | 41.75 | 57.39 | 760,687 | -23.24 | -32.65% |
1 Year | 87.83 | 98.67 | 41.75 | 66.66 | 600,993 | -39.89 | -45.42% |
3 Years | 125.31 | 180.06 | 41.75 | 95.85 | 652,532 | -77.37 | -61.74% |
5 Years | 63.90 | 324.25 | 41.75 | 126.32 | 650,605 | -15.96 | -24.98% |
QuidelOrtho Description
QuidelOrtho Corporation focuses on the development and manufacture of diagnostic testing technologies and solutions. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing products to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions. |